Abstract:Simple Summary Streptococcus suis serotype 2 (SS2) is a noteworthy zoonotic pathogen that has been responsible for substantial economic losses to the swine industry and a great threat to human health. In this study, the role of Pentraxin 3 (PTX3) during SS2 infection is explored to verify its potential as a new and effective biological agent that could partially resolve the problems posed by SS2. The study's results showed that PTX3 facilitated the phagocytosis of macrophage Ana-1 against SS2 strain HA9801, and contributed to inflammatory cell recruitment and cytokine IL-6 release in the mouse air pouch; thus, it was conductive to bacterial clearance during the SS2 infection. The presence of capsular polysaccharide of SS2 (CPS2) was identified as being required for PTX3 to trigger the inflammatory activation; this coordinating modulation of the host's innate immune response during the SS2 infection further suggested that PTX3 is a potential biological agent for the prevention and treatment of streptococcosis caused by SS2. However, the recommended dose of PTX3 must be further evaluated to avoid an excessive inflammatory response. Streptococcus suis serotype 2 (SS2) is a noteworthy zoonotic pathogen that has been responsible for large economic losses in pig production and a great threat to human health. Pentraxin 3 (PTX3) is an essential regulator of the innate immune response to bacterial pathogens; however, its role during SS2 infection is not fully understood. In this study, we found that the SS2 strain HA9801 induced a significant inflammatory response in the mouse air pouch model; this response was amplified by the treatment of exogenous PTX3 simultaneously in terms of the results of inflammatory cell recruitment and proinflammatory cytokine IL-6 production. In addition, PTX3 facilitated the phagocytosis of macrophage Ana-1 against SS2 strain HA9801. The supplementation of exogenous PTX3 significantly reduced the bacterial loads in a dose-dependent manner in lungs, livers and bloods of SS2-infected mice compared to the samples with HA9801 infection alone; this finding indicated that PTX3 may facilitate the bacterial clearance through enhancing the host inflammatory response during SS2 infection. Both PTX3 and SS2 capsular polysaccharide (CPS2) were required for the robust inflammatory response, implying that the host PTX3 protein and SS2 surface CPS2 modulate the host innate immune response in concert. All of these results suggested that PTX3 is a potential novel biological agent for the SS2 infection; however, the recommended dose of PTX3 must be evaluated strictly to avoid inducing an excessive inflammatory response that can cause serious tissue injury and animal death.

Host PTX3 Protein and Bacterial Capsule Coordinately Regulate the Inflammatory Response during <i>Streptococcus suis</i> Infection

Host PTX3 Protein and Bacterial Capsule Coordinately Regulate the Inflammatory Response during Streptococcus suis Infection

Flanking N- and C-terminal domains of PrsA in <i>Streptococcus suis</i> type 2 are crucial for inducing cell death independent of TLR2 recognition

Roles of the Putative Type IV-like Secretion System Key Component VirD4 and PrsA in Pathogenesis of Streptococcus Suis Type 2.

A Novel Pro-Inflammatory Protein of Streptococcus Suis 2 Induces the Toll-like Receptor 2-Dependent Expression of Pro-Inflammatory Cytokines in RAW 264.7 Macrophages Via Activation of ERK1/2 Pathway

Antibacterial effect of porcine PTX3 against Streptococcus suis type 2 infection

HP1717 Contributes to Streptococcus Suis Virulence by Inducing an Excessive Inflammatory Response and Influencing the Biosynthesis of the Capsule.

A Serine/threonine Phosphatase 1 of Streptococcus Suis Type 2 is an Important Virulence Factor.

PrsA Contributes to Streptococcus Suis Serotype 2 Pathogenicity by Modulating Secretion of Selected Virulence Factors.

Regulative synthesis of capsular polysaccharides in the pathogenesis of Streptococcus suis

Stk and Stp1 Participate in Streptococcus Suis Serotype 2 Pathogenesis by Regulating Capsule Thickness and Translocation of Certain Virulence Factors.

HP1330 Contributes to Streptococcus suis Virulence by Inducing Toll-Like Receptor 2- and ERK1/2-Dependent Pro-inflammatory Responses and Influencing In Vivo S. suis Loads.

Identification of an Autorepressing Two-Component Signaling System That Modulates Virulence in Streptococcus suis Serotype 2.

Two Spx regulators modulate stress tolerance and virulence in Streptococcus suis serotype 2.

Ribosomal Protein SA-Positive Neutrophil Elicits Stronger Phagocytosis and Neutrophil Extracellular Trap Formation and Subdues Pro-Inflammatory Cytokine Secretion Against Streptococcus Suis Serotype 2 Infection

Streptococcus suis Serotype 2 Type IV Secretion Effector SspA-1 Induces Proinflammatory Cytokine Production via TLR2 Endosomal and Type I Interferon Signaling

Thioredoxin A of Streptococcus Suis Serotype 2 Contributes to Virulence by Inhibiting the Expression of Pentraxin 3 to Promote Survival Within Macrophages

Advances in Pathogenesis of Streptococcus Suis Serotype 2

Streptococcus Suis 2 Transcriptional Regulator TstS Stimulates Cytokine Production and Bacteremia to Promote Streptococcal Toxic Shock-Like Syndrome

mRNA level of inflammation-associated cytokines of porcine alveolar macrophages cell lines 3D4/21 stimulated by Streptococcus suis serotype 2

The suppressive role of NLRP6 in host defense against Streptococcus suis infection